| Literature DB >> 35918641 |
Seon Young Hwang1, Sun Hwa Kim2, In Ae Uhm1, Jeong-Hun Shin3, Young-Hyo Lim4.
Abstract
BACKGROUND: As patients with myocardial infarction (MI) survive for a long time after acute treatment, it is necessary to pay attention to the prevention of poor prognosis such as heart failure (HF). To identify the influencing factors of adverse clinical outcomes through a review of prospective cohort studies of post-MI patients, and to draw prognostic implications through in-depth interviews with post-MI patients who progressed to HF and clinical experts.Entities:
Keywords: Content analysis; Focus group; Heart failure; Myocardial infarction; Prognosis
Mesh:
Year: 2022 PMID: 35918641 PMCID: PMC9344648 DOI: 10.1186/s12872-022-02753-z
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.174
Fig. 1Flow chart of the literature selection process
Characteristics of interviewed post-MI patients with HF transition (n = 11)
| Sex | Age | Education level | EF (%) at the time of MI | EF (%) at the time of HF | Period after MI (month) | Number of PCI | Comorbidity | Family CVD Hx† |
|---|---|---|---|---|---|---|---|---|
| M | 54 | Middle School | 45.5 | 32.0 | 29 | 4 | DM, CKD | No |
| M | 81 | University | 63.7 | 44.9 | 19 | 1 | HTN, DM | No |
| M | 40 | University | 52.0 | 39.0 | 14 | 3 | Yes | |
| M | 66 | High School | 48.0 | 49.0 | 17 | 2 | HTN | No |
| M | 72 | Elementary | 56.0 | 50.0 | 23 | 1 | HTN, DM | No |
| M | 67 | High School | 58.0 | 57.0 | 50 | 1 | HTN | Yes |
| M | 81 | Middle School | 57.0 | 41.0 | 72 | 2 | DM Asthma | No |
| F | 75 | Elementary | 65.0 | 42.0 | 68 | 2 | HTN, DM, CKD | Yes |
| F | 78 | Elementary | 64.5 | 20.0 | 173 | 4 | HTN, DM, CKD | No |
| F | 72 | Elementary | 48.0 | 35.0 | 74 | 2 | DM, HTN | No |
| F | 68 | University | 65.0 | 51.0 | 40 | 1 | HTN Dyslipidemia | No |
MI myocardial infraction, HF heart failure, EF ejection fraction, PCI percutaneous coronary intervention, CVD cardiovascular disease, Hx history, M male. DM diabetes mellitus, CKD chronic kidney disease, HTN hypertension, F female
†Family history of CVD includes diabetes, hypertension, dyslipidemia, arrhythmias, myocardial infarction, stroke, and heart failure
Long term follow-up cohort study analysis and affecting factors in patients with MI
| References | Source country | Subjects | Follow-up year | Adverse clinical outcomes (incidence rates) | Major affecting factors |
|---|---|---|---|---|---|
| Koren et al. [ | Central Israel, 8 hospitals | 1164 first MI patients | 13 | Recurrent MI or angina (45.6%) | Low education, low income, hypertension, diabetes, hypercholesterolemia, smoking, PCI, comorbidity index, Killip class, previous coronary heart disease |
| Kim et al. [ | Korea (KAMIR-NIH, nationwide registry) | 13,104 MI patients | 1 | Readmission and cardiac or cerebrovascular mortality (10.9%) | Age > 70, male, Killip class > 1, previous MI, previous angina, serum creatinine, PCI, PARADOCS (Pressure of ARtery elevAtion, Diabetes, Obesity, Cholesterol, Smoking) score |
| Norekvål et al. [ | Norway 1 hospital | 145 female MI patients(60-80y) | 10 | All-cause mortality (41%) | Old age, living alone, serum creatinine,, LVEF < 30%, marital status(divorced/widowed), low perceived health and quality of life |
| Daida et al. [ | Japan (nationwide registry) | 3597 ACS patients | 2 | All-cause mortality (6.3%) | Female, age ≥ 75, histories of MI, atrial fibrillation and cerebral infarction, hypertension, hyperlipidemia, smoking, eGFR < 60 ml/min, Killip class ≥ 2, peripheral arterial disease |
| Alhabib et al. [ | Saudi Arabia (nationwide registry) | 2233 ACS patients | 1 | All-cause mortality (8.1%) | Recurrent cardiac ischemia, recurrent MI, atrial fibrillation/flutter, previous stroke |
| Antoni et al. [ | Netherlands 1 hospital | 1453 STEMI patients | 4 | Cardiovascular mortality (4%) Hospitalization for HF (3%) | Age ≥ 70, Killip class ≥ 2, diabetes, left anterior descending coronary artery as the culprit vessel, multivessel disease, peak troponin T level ≥ 3.5 μg/L, LVEF ≤ 40% |
| Henderson et al. [ | England and Scotland (National Statistics) | 1810 NonST-ACS patients | 10 | All-cause mortality, (25.1%)@Cardiovascular death (15.1%) | Age, previous MI, heart failure, smoking status, diabetes, heart rate, and ST-segment depression |
| Steele et al. [ | United Kingdom 1 hospital | 3133 STEMI patients | 3 | Mortality (13.9%) | Old age, current smoker, ex-smoker, female, dyslipidemia, diabetes, previous MI, family history of chronic heart disease, chronic kidney disease stage IV or V, peripheral vascular disease |
| Barchielli et al. [ | Italy (nationwide registry) | 875 STEMI patients | 8 | All-cause mortality (49%) | Old age, Killip class > 1, cardiovascular or non-cardiovascular comorbidities, in-hospital cardiogenic shock, LVEF < 30%, treatment with aspirin and statin during hospitalization |
| Dohi et al. [ | United States and Germany (multicenter registry) | 8454 MI patients | 2 | Mortality (17.3%)@Recurrence of MI (3.3%) | Recurrent MI of unstable angina, diabetes, current smoker, multi-vessel disease, treatment of an in-stent re-stenotic lesion, low baseline hemoglobin and reduced creatinine clearance, antiplatelet agent factors, no use of statin at discharge |
| Chiang et al. [ | Taiwan (multicenter registry) | 3080 ACS patients | 1 | Mortality (22.4%) | Dual antiplatelet therapy ≥ 9 months, drug-eluting stents, chronic renal failure, in-hospital bleeding, NSTEMI, and antiplatelet discontinuation |
| Docherty et al. [ | United Kingdom | 13,202 MI patients | 2 | Sudden cardiac death (3.3%) | Old age, heart rate, smoking, Killip class, LVEF, history of prior atrial fibrillation, MI, HF, diabetes, eGFR |
| Pocock et al. [ | Europe, America, Asia,Australia(Global registry in 25 countries) | 9027 MI patients | 3 | Mortality (7.2%)@Recurrent cardiovascular events (1.4%) | Age ≥ 65 years, diabetes, second prior MI, chronic kidney disease, history of peripheral arterial disease or HF, cardiovascular hospitalization, diuretics, poor self-reported health |
| Munyombwe et al. [ | England (nationwide registry) | 9566 Survivors of MI patients | 4 | Reduced Health-related quality of life (69.1%) | Women, diabetes, previous MI and angina, chronic kidney disease, chronic obstructive pulmonary disease, cerebrovascular disease |
| Shah and Keeley [ | United States | 261 MI patients | 1 | Unplanned readmission (34%) | Recurrent MI, decompensated HF, low LVEF; diabetes |
| Carrick et al. [ | United Kingdom | 324 STEMI patients | 1 | All-cause mortality or HF(15%) | Hypertension, previous MI |
| Lopes et al. [ | Global registry in 24 countries | 14,703 MI patients | 3 | Mortality (2.2%) | Old age, baseline heart rate, creatinine clearance, new onset diabetes, previous MI |
| Gerber et al. [ | Minnesota in United States | 2596 MI patients | 7.6 | Mortality(42.9%) | Post-MI HF, MI severity, recurrent MI, comorbidity |
| Jernberg et al. [ | Sweden | 97,254 first MI patients | 1 | Cardiovascular events (18.3%) | Old age, prior MI, stroke, diabetes, HF, no index MI revascularization |
| Chen et al. [ | Taiwan | 11,183 Post MI patients | 3 | Cardiovascular events (13.8%) | Age, post-MI HF, hypertension, diabetes, prior stroke, chronic kidney disease, arterial fibrillation, underutilization of guideline-based medication |
| Park et al. [ | Korea (KAMIR-NIH, nationwide registry) | 10,455 MI patients | 3.5 | All-cause/cardiac death, MACE, HF (20.5%) | Old age(> 60), male, known/new onset diabetes, low BMI, low LVEF, multi-vessel disease, hypertension, dyslipidemia, prior stroke/angina/MI, renal failure |
ACS acute coronary syndrome, ACEi angiotensin converting enzyme inhibitor, STEMI ST-segment elevation myocardial infarction, NSTEMI non ST-segment elevation myocardial infarction, MI myocardial infarction, ARB angiotensin receptor blocker, eGFR estimated glomerular filtration rate, HF heart failure, KAMIR-NIH Korea acute myocardial infarction registry-national institute of health, PCI percutaneous coronary intervention, TIMI thrombolysis in myocardial infarction. LVEF left ventricular ejection fraction, MACE major adverse cardiovascular events
Disease perception extracted from in-depth interviews with post-MI patients
| Themes | Sub-themes | Statements |
|---|---|---|
| Exhaustion from endless treatment | Initially shocked but soon became oblivious the disease | |
| Getting tired from repeated hospitalizations due to recurrence | ||
| Lack of understanding about the disease | Inadequate self-care despite long term progression | |
| Becoming passive in disease management | ||
| Desperately seeking help from healthcare providers | Difficulty in approaching busy healthcare providers | |
| Desire for continuous attention and management from healthcare providers |
MI myocardial infarction
Perspectives of physicians and nurses on the prognosis of post-MI patients
| Themes | Sub-themes | Statements |
|---|---|---|
| Patients and situational factors in the acute phase increase the risk of poor prognosis | Irreversible acute-phase situational factors | |
| Patient's underlying chronic disease | ||
| Self-awareness as a chronic condition that must go together for a lifetime needed | Entering a new disease management | |
| Recognition that the disease can recur at any time | ||
| Importance of maintaining healthy behavior after the acute phase | Difficulty in self-care compliance | |
| Meaning of first discharge education from hospital | ||
| Strategies and educational efforts are needed for lifelong self-care of high risk patient | Tailored education on risk factors of patients for behavioral change | |
| Importance of cardiovascular nurses for continuous monitoring |
MI myocardial infarction